References
- Anane S, Chtourou O, Chedi A et al. [Onychomycosis in the elderly]. Ann. Dermatol. Venereol.134(10 Pt 1), 743–747 (2007).
- Arenas R. Las onicomicosis. Aspectos clínico-epidemiológicos, micológicos y terapéuticos. Gac. Méd. Méx.126, 84–91 (1990).
- Chang P, Logemann H. Onychomycosis in children. Int. J. Dermatol.33(8), 550–551 (1994).
- Findlay GH, Vismer HF, Sophianos T. The spectrum of paediatric dermatology. Analysis of 10,000 cases. Br. J. Dermatol.91(4), 379–387 (1974).
- Gupta AK, Sibbald RG, Lynde CW et al. Onychomycosis in children: prevalence and treatment strategies. J. Am. Acad. Dermatol.36(3 Pt 1), 395–402 (1997).
- Lateur N, Mortaki A, Andre J. Two hundred ninety-six cases of onychomycosis in children and teenagers: a 10-year laboratory survey. Pediatr. Dermatol.20(5), 385–388 (2003).
- Martinez Roig A, Torres Rodriguez JM. Twelve cases of tinea unguium in a pediatric clinic in 9 years. Eur. J. Pediatr.166(9), 975–977 (2007).
- Philpot CM, Shuttleworth D. Dermatophyte onychomycosis in children. Clin. Exp. Dermatol.14(3), 203–205 (1989).
- Romano C, Papini M, Ghilardi A, Gianni C. Onychomycosis in children: a survey of 46 cases. Mycoses48(6), 430–437 (2005).
- Orentreich N, Markofsky J, Vogelman JH. The effect of aging on the rate of linear nail growth. J. Invest. Dermatol.73(1), 126–130 (1979).
- Zaias N, Tosti A, Rebell G et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol.34(2 Pt 1), 302–304 (1996).
- Sugimoto R, Katoh T, Nishioka K. Isolation of dermatophytes from house dust on a medium containing gentamicin and flucytosine. Mycoses38(9–10), 405–410 (1995).
- Ruiz-Esmenjaud J, Arenas R, Rodríguez-Álvarez M, Monroy E, Fernández R. Tinea pedis y onicomicosis en niños de una comunidad indígena mazahua. Gac. Méd. Méx.139, 215–220 (2003).
- Baran R, Hay RJ, Garduno JI. Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J. Dermatolog. Treat.19(3), 168–175 (2008).
- Bonifaz A, Saul A, Mena C et al. Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases. J. Eur. Acad. Dermatol. Venereol.21(1), 115–117 (2007).
- Piraccini BM, Antonucci A, Rech G, Starace M, Misciali C, Tosti A. Onychomatricoma: first description in a child. Pediatr. Dermatol.24(1), 46–48 (2007).
- Baran R, Faergemann J, Hay RJ. Superficial white onychomycosis – a syndrome with different fungal causes and paths of infection. J. Am. Acad. Dermatol.57(5), 879–882 (2007).
- Piraccini BM, Tosti A. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch. Dermatol.140(6), 696–701 (2004).
- Elewski BE. Clinical pearl: proximal white subungual onychomycosis in AIDS. J. Am. Acad. Dermatol.29(4), 631–632 (1993).
- Herrod HG. Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. J. Pediatr.116(3), 377–382 (1990).
- Kacar N, Ergin S, Ergin C, Erdogan BS, Kaleli I. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial. Clin. Exp. Dermatol.32(1), 1–5 (2007).
- Gupta AK, Skinner AR. Onychomycosis in children: a brief overview with treatment strategies. Pediatr. Dermatol.21(1), 74–79 (2004).
- Seebacher C, Brasch J, Abeck D et al. Onychomycosis. Mycoses50(4), 321–327 (2007).
- Takahata Y, Hiruma M, Shiraki Y, Tokuhisa Y, Sugita T, Muto M. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week). Mycoses52(1), 72–76 (2009).
- Tosti A, Piraccini BM, Stinchi C, Colombo MD. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology197(2), 162–166 (1998).
- Arbegast KD, Lamberty LF, Koh JK, Pergram JM, Braddock SW. Congenital candidiasis limited to the nail plates. Pediatr. Dermatol.7(4), 310–312 (1990).
- Tosti A, Piraccini BM, Lorenzi S, D’Antuono A. Candida onychomycosis in HIV infection. Eur. J. Dermatol.8(3), 173–174 (1998).
- Rabson AR. Chronic mucocutaneous candidiasis – an immunological mystery. S. Afr. Med. J.97(11), 1190–1192 (2007).
- Eyerich K, Foerster S, Rombold S et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol.128(11), 2640–2645 (2008).
- Proust-Lemoine E, Wemeau JL. Apeced syndrome or autoimmune polyendocrine syndrome Type 1. Presse Med.37(7–8), 1158–1171 (2008).
- Tosti A, Piraccini BM, Vincenzi C, Cameli N. Itraconazole in the treatment of two young brothers with chronic mucocutaneous candidiasis. Pediatr. Dermatol.14(2), 146–148 (1997).
- Liu X, Hua H. Oral manifestation of chronic mucocutaneous candidiasis: seven case reports. J. Oral Pathol. Med.36(9), 528–532 (2007).
- Suzuki T, Imamura A. [A case of chronic mucocutaneous candidasis cured with micafungin]. Kansenshogaku Zasshi79(2), 143–148 (2005).
- Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr. Infect. Dis. J.20(2), 197–206 (2001).